In this context it would be interesting to examine the efficacy of pharmacological blockade of CxHC and pannexin-1 channels, including specific inhibitors [17] (e.g., Gap19, Gap26, Gap27), to prevent development of cardiac arrhythmias. Here, PANX1 is linked to chronic obstructive pulmonary disease.